Exosomal melanotransferrin as a potential biomarker for metastatic melanoma
A. Bonhoure, L. Henry, M. Morille, N. Assaoui, G. Bellot, P.-E. Stoebner, M. Vidal
This paper identifies exosomal melanotransferrin as a potential noninvasive biomarker for metastatic melanoma by demonstrating its detection in plasma samples using an ELISA.
bioRxiv · Nov 9, 2020 · PreprintCell Biology